Dopamine D3 Receptors: A Potential Target to Treat Motivational Deficits in Parkinson’s Disease
Current Topics in Behavioral Neurosciences · 2022
DOI: 10.1007/7854_2022_316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Topics in Behavioral Neurosciences, 2022. Verfasst von Mathieu Favier und 3 weiteren Autor:innen. Beteiligte Einrichtung: Douglas Mental Health University Institute, McGill University, Verdun, QC, Canada. Hauptthemen laut MEDLINE: Parkinson Disease, Apathy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 104 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Douglas Mental Health University Institute, McGill University, Verdun, QC, Canada.
- Inserm, U1216, Univ. Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.
- Inserm, Délégation régionale Provence-Alpes-Côte d'Azur et Corse, Marseille CEDEX 09, France.
- Inserm, U1216, Univ. Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France. sebastien.carnicella@inserm.fr.
Zitieren
APA
Favier, M., Carcenac, C., Savasta, M., & Carnicella, S. (2022). Dopamine D3 Receptors: A Potential Target to Treat Motivational Deficits in Parkinson’s Disease. Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2022_316
Vancouver
Favier M, Carcenac C, Savasta M, Carnicella S. Dopamine D3 Receptors: A Potential Target to Treat Motivational Deficits in Parkinson’s Disease. Current Topics in Behavioral Neurosciences. 2022. doi:10.1007/7854_2022_316
BibTeX
@article{Favier2022,
author = {Favier, Mathieu and Carcenac, Carole and Savasta, Marc and Carnicella, Sebastien},
title = {Dopamine D3 Receptors: A Potential Target to Treat Motivational Deficits in Parkinson’s Disease},
journal = {Current Topics in Behavioral Neurosciences},
year = {2022},
doi = {10.1007/7854_2022_316}
}
EUVIMED